Why AdaptHealth Corp.’s (AHCO) Stock Is Down 13.73%

By Cynthia McLaughlin
July 31, 2026
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate AdaptHealth Corp. before investing.

In this article, we go over a few key elements for understanding AdaptHealth Corp.’s stock price such as:

  • AdaptHealth Corp.’s current stock price and volume
  • Why AdaptHealth Corp.’s stock price changed recently
  • Upgrades and downgrades for AHCO from analysts
  • AHCO’s stock price momentum as measured by its relative strength

About AdaptHealth Corp. (AHCO)

Before we jump into AdaptHealth Corp.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Want to learn more about AdaptHealth Corp.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about AdaptHealth Corp..

Learn More About A+ Investor

AdaptHealth Corp.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, AdaptHealth Corp.’s stock price was $10.800.

AdaptHealth Corp. is up 1.12% from its previous closing price of $10.680.

During the last market session, AdaptHealth Corp.’s stock traded between $10.440 and $10.810. Currently, there are approximately 135.78 million shares outstanding for AdaptHealth Corp..

AdaptHealth Corp.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

AdaptHealth Corp. Stock Price History

AdaptHealth Corp.’s (AHCO) price is currently up 3.65% so far this month.

During the month of July, AdaptHealth Corp.’s stock price has reached a high of $11.700 and a low of $9.740.

Over the last year, AdaptHealth Corp. has hit prices as high as $13.430 and as low as $8.505. Year to date, AdaptHealth Corp.’s stock is up 8.43%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused AdaptHealth Corp. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there were 0 analysts who downgraded AdaptHealth Corp.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate AdaptHealth Corp.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on AdaptHealth Corp.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

AdaptHealth Corp.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about AdaptHealth Corp. (AHCO) by visiting AAII Stock Evaluator.

Relative Price Strength of AdaptHealth Corp.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, AdaptHealth Corp. has a weighted four-quarter relative price strength of -2.94%, which translates to a Momentum Score of 41 and is considered to be Average.

Want to learn more about how AdaptHealth Corp. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

AdaptHealth Corp. Stock Price: Bottom Line

As of July 31, 2026, AdaptHealth Corp.’s stock price is $10.800, which is up 1.12% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like AdaptHealth Corp. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
Zweig Screen: 11.3% Compared to S&P 500
at only 6.9%

Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.